Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BrightSpring Health Services (BTSG) Change in Inventory (2023 - 2025)

BrightSpring Health Services' Change in Inventory history spans 3 years, with the latest figure at $175.6 million for Q4 2025.

  • For Q4 2025, Change in Inventory rose 8.25% year-over-year to $175.6 million; the TTM value through Dec 2025 reached $177.9 million, down 24.78%, while the annual FY2025 figure was $177.9 million, 24.78% down from the prior year.
  • Change in Inventory reached $175.6 million in Q4 2025 per BTSG's latest filing, up from $13.8 million in the prior quarter.
  • In the past five years, Change in Inventory ranged from a high of $175.6 million in Q4 2025 to a low of -$103.3 million in Q1 2025.
  • Average Change in Inventory over 3 years is $32.1 million, with a median of $19.2 million recorded in 2023.
  • The largest YoY upside for Change in Inventory was 11903.53% in 2025 against a maximum downside of 238.86% in 2025.
  • A 3-year view of Change in Inventory shows it stood at $24.6 million in 2023, then surged by 559.98% to $162.2 million in 2024, then rose by 8.25% to $175.6 million in 2025.
  • Per Business Quant, the three most recent readings for BTSG's Change in Inventory are $175.6 million (Q4 2025), $13.8 million (Q3 2025), and $91.8 million (Q2 2025).